title: Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.
authors.affiliation: Durham Regional Cancer Centre, Oshawa, Canada.
authors.forename: Jose
authors.initials: J
authors.lastname: Chang
authors.forename: Felix
authors.initials: F
authors.lastname: Couture
authors.forename: Scott
authors.initials: S
authors.lastname: Young
authors.forename: Kara-Lee
authors.initials: KL
authors.lastname: McWatters
authors.forename: Catherine Y
authors.initials: CY
authors.lastname: Lau
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000139:chemically induced* / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001803:Blood Transfusion; D001943:Breast Neoplasms / Q000188:drug therapy*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D005221:Fatigue; D005260:Female; D006397:Hematinics / Q000008:administration & dosage / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007279:Injections, Subcutaneous; D008875:Middle Aged; D011788:Quality of Life; D011994:Recombinant Proteins; D016896:Treatment Outcome
chemical_list: D006397:Hematinics; D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa